02 Oct CellOPTIQ® HCA Confirmed as Leader in Assessing Cardiotoxicity
BioCity, Glasgow based Clyde Biosciences, the leader in cardiac cell function assessment, announced that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new...